Tag: new therapy

Promising new therapy for NTRK fusion cancer

August 24, 2021

by John Battersby In the past the prognosis for patients with Neurotrophic tyrosine receptor kinase (NTRK) fusion cancer, was poor as the cancer did not respond well to most available therapies. But now a new class of drug, recently approved by the FDA and now available in more than 40 countries, is offering new hope […]

Continue Reading